Welcome to our dedicated page for Plexus SEC filings (Ticker: PLXS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Plexus Corp’s disclosures can feel like assembling a multilayer circuit board—every footnote, customer-concentration table, and segment margin matters. Yet the company’s 10-K often exceeds 250 pages and its 8-K material events arrive without notice.
Stock Titan eliminates the guesswork. Our AI parses each Plexus SEC filing the moment it hits EDGAR, then delivers plain-English highlights so you can:
- See Plexus insider trading Form 4 transactions and receive Plexus Form 4 insider transactions real-time alerts.
- Compare backlog trends inside the Plexus quarterly earnings report 10-Q filing.
- Review supply-chain risk updates with our Plexus 8-K material events explained summaries.
Need to understand cost-plus defense contracts or how healthcare orders affect margins? Our AI-powered summaries point you straight to the notes that matter, making Plexus SEC filings explained simply.
For deeper dives, open the original documents beside concise annotations: the Plexus annual report 10-K simplified section decodes multi-segment revenue, while our proxy overview answers your search for Plexus proxy statement executive compensation. Investors tracking leadership moves can monitor Plexus executive stock transactions Form 4 without scanning dozens of PDFs.
Whether you’re researching contract manufacturing exposure or seeking a quick Plexus earnings report filing analysis, Stock Titan’s real-time data and expert context let you act with clarity, not guesswork.
Plexus Corp (PLXS) reported a Form 4/A by Director Karen Rapp amending a prior filing to correct the size of a restricted stock unit grant. On February 3, 2025, 1,370 Restricted Stock Units were awarded under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3. Each RSU represents one share of common stock and vests on February 3, 2026. Following the transaction, 1,370 derivative securities were beneficially owned directly.
Plexus Corp (PLXS) disclosed an amended Form 4 for director J. Joel Quadracci, reporting the acquisition of 1,370 Restricted Stock Units on 02/03/2025 under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each RSU represents a contingent right to receive one share of Plexus common stock, and the RSUs vest on 02/03/2026. Following the reported transaction, the filing lists 1,370 derivative securities beneficially owned, held directly. The amendment states it was filed to correct the number of RSUs granted.
Plexus Corp (PLXS) filed a Form 4/A reporting a corrected equity award to a board member. Director Randy J. Martinez received 1,370 Restricted Stock Units on 02/03/2025 under the 2024 Omnibus Incentive Plan. Each RSU represents the right to receive one share of Plexus common stock. The RSUs vest on 02/03/2026. The filing states the amendment was made to correct the number of RSUs granted. Ownership of the derivative securities is reported as Direct.
Plexus Corp. (PLXS) reported an insider update: director Rainer Jueckstock filed an amended Form 4 to correct an equity award. The filing states a grant of 1,370 Restricted Stock Units on February 3, 2025 under the Plexus Corp. 2024 Omnibus Incentive Plan.
Each RSU represents a contingent right to receive one share of Plexus common stock, and the RSUs vest on February 3, 2026. Following the correction, the reporting person shows 1,370 derivative securities held directly. The amendment is expressly to correct the number of RSUs granted.
Plexus Corp (PLXS) reported an amended insider transaction. The company’s Chairman of the Board and Director filed a Form 4/A correcting the number of restricted stock units granted on 02/03/2025 to 1,370 RSUs under the Plexus Corp. 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of common stock and vests on 02/03/2026.
Following the reported transaction, the filing lists 1,370 derivative securities beneficially owned, held directly. The amendment states it was filed to correct the number of RSUs granted.
Plexus Corp (PLXS)1,370 restricted stock units under the Plexus Corp. 2024 Omnibus Incentive Plan, with vesting on February 3, 2026.
The transaction date is February 3, 2025, and the reported ownership is direct. Each RSU represents a contingent right to receive one share of Plexus common stock.
Plexus Corp (PLXS) reported insider activity by its President & CEO and Director, Todd P. Kelsey. On 10/29/2025, he disposed of 5,000 shares of common stock under transaction code G, which denotes a bona fide gift. Following this transaction, he beneficially owned 64,214 shares, held directly.
This reflects a charitable or personal transfer rather than a market sale, as indicated by the gift code and footnote stating the shares “were given as a bona fide gift.”
Plexus Corp. (PLXS) disclosed an insider transaction on Form 4. Exec. VP & CFO Patrick J. Jermain sold 1,998 shares of common stock at $142.8 on 10/27/2025.
Following the sale, he beneficially owned 18,961 shares directly. He also held 3,719 shares indirectly through the company’s 401(k) Retirement Plan, based on the plan trustee’s most recent report.
Plexus Corp. (PLXS) filed an 8-K reporting earnings timing. The company announced results for its fiscal fourth quarter and year ended September 27, 2025, and furnished a related press release.
The press release is included as Exhibit 99.1, dated October 22, 2025. Common stock trades on the Nasdaq Global Select Market under PLXS.
Plexus Corp (PLXS) insider Todd P. Kelsey, who serves as President & CEO and a director, reported a sale of 1,500 shares of common stock on 10/01/2025 at a price of $143.70 per share. The filing shows 69,214 shares remain beneficially owned by the reporting person after the transaction. The Form 4 notes the shares were sold under a Rule 10b5-1 trading plan adopted on August 16, 2024, and the filing was signed via attorney-in-fact on 10/02/2025.